Biogen (BIIB) Current Assets (2009 - 2026)

Biogen's Current Assets history runs 18 years deep, the most recent figure standing at $9.2 billion for Q1 2026.

• In Q1 2026, Current Assets rose 20.51% year-over-year to $9.2 billion; the TTM figure through Mar 2026 stood at $9.2 billion (up 20.51% YoY), while the FY2025 annual figure was $9.0 billion, up 20.35% from the prior year.
• Current Assets was $9.2 billion for Q1 2026 at Biogen, up from $9.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $10.4 billion in Q2 2023 to a low of $6.8 billion in Q1 2024.
• Historically, Current Assets has averaged $8.4 billion across 5 years, with a median of $8.5 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Current Assets surged 36.35% in 2022, then tumbled 31.86% in 2024.
• A 5-year view of Current Assets shows it stood at $9.8 billion in 2022, then slipped by 29.94% to $6.9 billion in 2023, then grew by 8.71% to $7.5 billion in 2024, then gained by 20.35% to $9.0 billion in 2025, then rose by 2.41% to $9.2 billion in 2026.
• The last three Current Assets figures came in at $9.2 billion (Q1 2026), $9.0 billion (Q4 2025), and $8.9 billion (Q3 2025), per Business Quant data.